MP合并hMPV和SP感染的重症肺炎患儿1例药学监护  

Pharmaceutical care for a child with severe pneumonia infected by MP combined with hMPV and SP

作　　者：段小菊 毕文超 侯静静 王岩[1] 谷雨 刘宪勇 郑俊青[2] Duan Xiaoju;Bi Wenchao;Hou Jingjing;Wang Yan;Gu Yu;Liu Xianyong;Zheng Junqing(Department of Pharmacy,Shandong Corps Hospital of the Chinese People's Armed Police Forces,Jinan 250014,China;Department of Pediatrics,Jinan Maternity and Child Care Hospital,Jinan 250218,China)

机构地区：[1]中国人民武装警察部队山东省总队医院药剂科,济南250014 [2]济南市妇幼保健院儿科,济南250218

出　　处：《国际医药卫生导报》2024年第10期1716-1719,共4页International Medicine and Health Guidance News

基　　金：山东省自然科学基金(ZR2020QH366)。

摘　　要：临床药师全程参与1例肺炎支原体(MP)合并偏肺病毒(hMPV)和肺炎链球菌(SP)感染的重症肺炎患儿药学监护,在患儿病情复杂、医师忽略MP感染、超说明书用药和违反传统理论联合用药的情况下,查阅资料,结合病情深入剖析,及时提供安全有效的治疗方案分析和建议,监测疗效和不良反应,进行用药指导;较好地保障了患儿用药的安全性和有效性,提供了有效的药学服务,同时为此类患儿的药物治疗和监护提供参考。The clinical pharmacists participated in the pharmaceutical care of a child with severe pneumonia infected by Myocoplasima pneumonia(MP)combined with human metapneumovirus(hMPV)and streptococcus pneumonia(SP)throughout the entire process.In cases where the physicians ignored MP,used off-label drug,and violated traditional theory of drug combination with the complex disease,the clinical pharmacists timely provided safe and effective analyses and suggestions of the treatment plan,monitored the efficacies and adverse reactions,and provided medication guidance through searching for information and in-depth analyses of the disease situation.It ensured the safety and effectiveness of medication for the child effectively,provided the effective pharmaceutical services for clinical practice,and provided reference for drug treatment and care of such patients at the same time.

关 键 词：肺炎支原体 偏肺病毒 肺炎链球菌 重症肺炎 患儿 药学监护 

分 类 号：R969[医药卫生—药理学]